Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment (Q67912725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1846847%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1846847%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

19 September 2019

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

8 December 2022

author name string

P. Bonomi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

M. Gale

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

K. Rowland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

S. G. Taylor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

S. Purl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

S. Reddy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

M. S. Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

A. Phillips

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

C. F. Kittle

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

W. Warren

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1846847

8 December 2022

language of work or name

English

0 references

publication date

1 February 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1846847%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:036030169190099P?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

https://api.elsevier.com/content/article/PII:036030169190099P?httpAccept=text/plain

8 December 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

International Journal of Radiation Oncology Biology Physics

8 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1846847%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1846847%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1846847%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

247-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1846847%20AND%20SRC:MED&resulttype=core&format=json

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

19 September 2019

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy

8 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

Nonparametric Estimation from Incomplete Observations

8 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria.

8 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

Assessment of the Role of Surgery for Control of Lung Cancer

8 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

A new international staging system for lung cancer

8 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group

8 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

Radiotherapy in the management of locally advanced lung cancer of all cell types: final report of randomized trial

8 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer

8 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0360-3016(91)90099-P

8 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1846847%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference